Breathe Well Live Well
|
Roche Asthma Drug Meets Primary Endpoint In Phase II Study
Fox Business VX) Thursday said that a phase II study of its investigational asthma treatment lebrikizumab met its primary endpoint in a mid-stage trial. –Lebrikizumab isa humanized monoclonal antibody designed to block interleukin-13 (IL-13) cytokine. … IL-13 Blocker Helps Asthma Control Experimental Drug Promising Against Tough-to-Treat Asthma Roche asthma drug shows promise in mid-stage trial |
View full post on asthma – Google News
|
Actelion's novel CRTH2 antagonist meets primary endpoint in Phase II study in …
Reuters (press release) This study complements the positive proof-of-mechanism study in asthma reported in 2009. Together, these studies provide substantial information that will guide us in the further development of this compound and our follow-up molecules in allergic … |
View full post on asthma – Google News
 SkySports (blog) |
Bellamy meets fans in hospital
BBC News Bellamy spoke about his visits to the hospital as a boy with asthma, while his family were thankful for the care given to his daughter, who developed … Bellamy's high praise for 'special' hospital |
View full post on asthma – Google News
North Haven High School Air Quality Meets Standards
Although a clean air report has been issued for North Haven High School, the parent who complained on behalf of her asthmatic son is dissatisfied and still has questions. A limited indoor…
Read more on North Haven Courier